Navigation Links
EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
Date:10/25/2007

Significant Survival Advantage Shown in Lung Cancer Model

ROCKVILLE, Md., Oct. 25 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of interim Phase 1 pharmacokinetic results for its antimitotic agent, ENMD-1198, together with preclinical antitumor activity results. The data were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held this week in San Francisco, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Pharmacokinetic results demonstrate that once a day orally-administered ENMD-1198 has good pharmacokinetic (PK) parameters in cancer patients participating in a Phase 1 clinical study. In the first four cohorts of the dose-escalation trial in advanced cancer patients, ENMD-1198 demonstrated dose proportional PK exposures across the range of 5-30 mg/m2. ENMD-1198, a new chemical entity (NCE) based on a modified chemical structure of 2- methoxyestradiol (2ME2), was designed to decrease metabolism while retaining 2ME2's multiple mechanisms of action, including inducing apoptosis, disrupting microtubules, and inhibiting HIF-1alpha.

ENMD-1198 was evaluated in a preclinical model of non-small cell lung cancer (NSCLC) and demonstrated a three-fold increase in survival compared to Cisplatin, an approved agent for the treatment of this disease. Approximately 80% of the ENMD-1198 treated models remained on study until tumor dissemination evaluation. In prior preclinical stud
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
5. EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
6. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
7. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...f., Nov. 19 Alexza Pharm...that its corporate presentation will be webcast li...e Conference on Wednesday, December 2, 2009 at 9:0...cast from The New York Palace Hotel in New York an...ident and CEO. ,, To access the live presenta...
(Date:11/19/2009)... Nov. 19 Ligon Discovery, Inc., wh...hnology to find drugs against high-value targets, ...ancing led by incTANK Ventures. The company will u...ampaign that will screen over 100 high-value disea...Ventures General Partner Christian Bailey joins th...
(Date:11/19/2009)... Nov. 19 Mach 7 Technologies, a ...re image management solutions, and QStar Technolog... PACS- neutral archive solution through their comm...international leader in providing digital image di...industry. Under the agreement, Data Distributing ...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 1BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 3Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 1Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 3
(Date:11/20/2009)... Senators and Congressmen in Compe...r their Health Care Vote , ...tors and congressmen running for re-election next ...l guru Charlie Cook, may come to regret voting for...ll, according to a breaking Zogby International/ O...
(Date:11/20/2009)..., HAIFA, Israel, November 20 /PRNewswire-Fi...CVSL.OB), http://www.CVSLMEDICAL.COM , a leading,...ology, today announced that,the company,s Board of...ions,in Europe, Canada and the Far East for its pr...plicable for all angioplasty (PCTA) procedures. ,...
(Date:11/20/2009)...orial published online November 20 in the Journal...xaggerated fears and hopes that often appear in ne...ides guidance for both the media and journals to h....D., M.S., and Steven Woloshin, M.D., M.S., of Cen...stitute for Health Policy and Clinical Practice in...
(Date:11/20/2009)... Based out of Dallas, TX, the new ...uality products that are made in the USA. , ... 2009 -- blue sky scrubs is an independent medical...ty, design, production and distribution of hospita...y selling their products via their online boutique...
(Date:11/20/2009)...activity remains high and is expected to continue,...ay News) -- Some areas of the United States are se...l health official said Friday, and while the disea...om the 46 states reported last week. , "We are ...ty around the country, but there is still a lot of...
Breaking Medicine News(10 mins):Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
...es from the American Academy of Pediatrics should ...reterm or low birth weight infant home from the ho...sportation of Preterm and Low Birth Weight Infants... for Children, provides guidelines for secure tran...
...sons entering U.S. for signs of sickness , ...Barack Obama said Monday that the threat posed by ..."not a cause for alarm," as the United States bega...public health emergency as a precautionary tool to...
...ay, the White House announced the appointment of C...merican Board of Internal Medicine to President Ba...chnology (PCAST). Dr. Cassel joins 19 other scien...rch. , , "I am honored to join such an illustriou...
...adalafil may improve lower urinary tract symptoms ...searchers from Nashville, Dallas, San Antonio and ...e 104th Annual Scientific Meeting of the American ...six month diagnosis of BPH-LUTS with an Internatio...
...dical Nurse Training, Inc. discusses training nurs... the Assistant Director of Nursing at Johns Hopkin...edical industry potentially, $200 Billion annually... 200 billion dollars yearly. Most of these savings...
...nhance Industry Standards for Quality Screening in...lar Diagnostics , , MADISON, N.J., April 27 ...into genetic factors affecting the accuracy and qu...agnostics . Quest Diagnostics Incorporated (NYSE: ...
Other Medicine News:Health News:Safely transporting a preterm or low birth weight infant 2Health News:Obama Says Swine Flu Outbreak No Cause for 'Alarm' 2Health News:Obama Says Swine Flu Outbreak No Cause for 'Alarm' 3Health News:Obama Says Swine Flu Outbreak No Cause for 'Alarm' 4Health News:Obama Says Swine Flu Outbreak No Cause for 'Alarm' 5Health News:Christine Cassel, MD Appointed to President Obama's Council of Advisors on Science and Technology 2Health News:Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction 2Health News:Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually 2Health News:Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening 2Health News:Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening 3Health News:Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening 4Health News:Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening 5
...ne rubber with a wire reinforced endobronchial tub...ubber, Silbronco is soft and less traumatic to the...not soften like PVC tubes, which makes Silbronco s...o especially useful when a tumor lifts up the left...
Arndt Endobronchial Blocker - Spherical Balloon
...alpel, introducer, tracheal cannula, neck tape, 15...,The Mini-Trach® II kit provides the necessary...,With the Mini-Trach® II kit, a small bore can...rough the cricothyroid membrane using a guarded sc...
...ck handle - Chrome-plated brass. Rusch offers a re...cope handles that are compatible with all standard...dards. The designs of these handles have been cont...d over to minimize maintenance requirements. They ...
Medicine Products: